FI104149B - Menetelmä valmistaa hitaasti vapauttavia seoksia - Google Patents

Menetelmä valmistaa hitaasti vapauttavia seoksia

Info

Publication number
FI104149B
FI104149B FI913646A FI913646A FI104149B FI 104149 B FI104149 B FI 104149B FI 913646 A FI913646 A FI 913646A FI 913646 A FI913646 A FI 913646A FI 104149 B FI104149 B FI 104149B
Authority
FI
Finland
Prior art keywords
slow release
process produces
release compositions
produces slow
compositions
Prior art date
Application number
FI913646A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI913646L (fi
FI104149B1 (fi
FI913646A0 (fi
Inventor
Jean-Marc Ruiz
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of FI913646A0 publication Critical patent/FI913646A0/fi
Publication of FI913646L publication Critical patent/FI913646L/fi
Application granted granted Critical
Publication of FI104149B1 publication Critical patent/FI104149B1/fi
Publication of FI104149B publication Critical patent/FI104149B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Glanulating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
FI913646A 1990-08-01 1991-07-31 Menetelmä valmistaa hitaasti vapauttavia seoksia FI104149B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (4)

Publication Number Publication Date
FI913646A0 FI913646A0 (fi) 1991-07-31
FI913646L FI913646L (fi) 1992-02-02
FI104149B1 FI104149B1 (fi) 1999-11-30
FI104149B true FI104149B (fi) 1999-11-30

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913646A FI104149B (fi) 1990-08-01 1991-07-31 Menetelmä valmistaa hitaasti vapauttavia seoksia

Country Status (30)

Country Link
US (1) US5213812A (enExample)
JP (1) JP2818704B2 (enExample)
KR (1) KR920003962A (enExample)
AT (1) AT396425B (enExample)
AU (2) AU649696B2 (enExample)
BE (1) BE1004772A3 (enExample)
CA (1) CA2048270C (enExample)
CH (1) CH682715A5 (enExample)
DE (1) DE4125542A1 (enExample)
DK (1) DK175756B1 (enExample)
ES (1) ES2046083B1 (enExample)
FI (1) FI104149B (enExample)
FR (1) FR2665360B1 (enExample)
GB (1) GB9016885D0 (enExample)
GR (1) GR1001512B (enExample)
HK (1) HK33294A (enExample)
IE (1) IE65124B1 (enExample)
IN (1) IN178446B (enExample)
IT (1) IT1251788B (enExample)
LU (1) LU87982A1 (enExample)
MA (1) MA22245A1 (enExample)
MY (1) MY107500A (enExample)
NL (1) NL194637C (enExample)
NO (1) NO300158B1 (enExample)
NZ (1) NZ238981A (enExample)
OA (1) OA09387A (enExample)
PT (1) PT98497B (enExample)
SE (1) SE505734C2 (enExample)
TN (1) TNSN91067A1 (enExample)
ZA (1) ZA915565B (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
JP2930421B2 (ja) * 1994-02-28 1999-08-03 メディノヴァ メディカル コンサルティング ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤組成物、その製造方法及びその使用方法
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
CA2267930A1 (en) * 1996-10-09 1998-04-16 Nobuyuki Takechi A method for producing a microparticle
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
EP1079967A4 (en) 1998-04-13 2003-07-23 Luminex Corp LIQUID MARKING USING FLUORESCENT MICROPARTICLES
OA11728A (en) * 1998-12-16 2005-02-01 Aventis Pharma Inc Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same.
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
DE60138641D1 (de) 2000-10-27 2009-06-18 Baxter Healthcare Sa Herstellung von mikrokügelchen
US20030064033A1 (en) * 2001-08-16 2003-04-03 Brown Larry R. Propellant-based microparticle formulations
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
US8075919B2 (en) * 2003-07-18 2011-12-13 Baxter International Inc. Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
WO2005009375A2 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
EP1765294B1 (en) 2004-05-12 2008-09-24 Baxter International Inc. Nucleic acid microspheres, production and delivery thereof
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
CN103393601A (zh) * 2004-05-12 2013-11-20 巴克斯特国际公司 含有蛋白并在高浓度蛋白下显示可注射性的微球体
US7884085B2 (en) * 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
CA2573341A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
EP1773264A1 (en) * 2004-07-13 2007-04-18 Altairnano, Inc Ceramic structures for controlled release of drugs
EP1812920A1 (en) * 2004-10-29 2007-08-01 Adhesives Research, Inc. Microscopic tagging system for security identification
MX2007013356A (es) * 2005-04-27 2008-03-26 Baxter Int Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
JP2009505824A (ja) * 2005-08-23 2009-02-12 アルテアナノ インコーポレイテッド 高度な光触媒のリンドープアナターゼＴｉＯ２組成物及びその製造方法
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
WO2007103812A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for low temperature production of nano-structured iron oxide coatings
WO2007103829A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for production of metal oxide coatings
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
AU2007281737B2 (en) 2006-08-04 2013-09-19 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
MX2009003661A (es) * 2006-10-06 2009-04-22 Baxter Int Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) * 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
CN101686939B (zh) * 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
AU2009237577B2 (en) 2008-04-18 2014-06-05 Baxter Healthcare Sa Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100078848A1 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010132763A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
WO2010138193A2 (en) 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
US20110076771A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
CN107029223A (zh) 2010-05-26 2017-08-11 西莱克塔生物科技公司 合成纳米载体联合疫苗
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
JP2014521687A (ja) 2011-07-29 2014-08-28 セレクタ バイオサイエンシーズ インコーポレーテッド 体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
US10695406B2 (en) 2014-05-27 2020-06-30 The University Of Queensland Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (enExample) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
EP0366058A3 (en) * 1988-10-27 1991-03-20 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
GB9016885D0 (en) 1990-09-12
FR2665360A1 (fr) 1992-02-07
ZA915565B (en) 1992-04-29
DK175756B1 (da) 2005-02-14
FI913646L (fi) 1992-02-02
NL9101306A (nl) 1992-03-02
NO300158B1 (no) 1997-04-21
LU87982A1 (fr) 1992-04-15
AU666808B2 (en) 1996-02-22
OA09387A (fr) 1992-09-15
MA22245A1 (fr) 1992-04-01
IN178446B (enExample) 1997-05-03
BE1004772A3 (fr) 1993-01-26
CH682715A5 (fr) 1993-11-15
SE505734C2 (sv) 1997-10-06
TNSN91067A1 (fr) 1992-10-25
CA2048270C (en) 1997-02-25
AU5939394A (en) 1994-06-02
ATA152591A (de) 1993-01-15
CA2048270A1 (en) 1992-02-02
ITMI911953A0 (it) 1991-07-15
ITMI911953A1 (it) 1993-01-15
KR920003962A (ko) 1992-03-27
FI104149B1 (fi) 1999-11-30
DK141891D0 (da) 1991-07-31
FI913646A0 (fi) 1991-07-31
ES2046083B1 (es) 1994-08-01
DK141891A (da) 1992-02-02
AU8146691A (en) 1992-02-06
HK33294A (en) 1994-04-22
US5213812A (en) 1993-05-25
NL194637C (nl) 2002-10-04
FR2665360B1 (fr) 1995-02-10
GR910100330A (en) 1992-08-31
GR1001512B (el) 1994-02-28
SE9102249D0 (sv) 1991-07-26
ES2046083A1 (es) 1994-01-16
NO912986D0 (no) 1991-07-31
SE9102249L (sv) 1992-02-02
PT98497A (pt) 1992-06-30
IT1251788B (it) 1995-05-26
JPH05178740A (ja) 1993-07-20
AT396425B (de) 1993-09-27
IE912700A1 (en) 1992-02-12
JP2818704B2 (ja) 1998-10-30
AU649696B2 (en) 1994-06-02
MY107500A (en) 1995-12-30
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
IE65124B1 (en) 1995-10-04
DE4125542A1 (de) 1992-02-06
NZ238981A (en) 1992-11-25
PT98497B (pt) 1997-10-31

Similar Documents

Publication Publication Date Title
FI914174A7 (fi) Menetelmä piperidyylialkyyliamiinien valmistamiseksi
FI910352A7 (fi) Paikallinen koostumus
FI931964L (fi) Bryningskomposition
FI932850A7 (fi) Process foer kontinuerlig framstaellning av hoegmodulsprodukter av hoegmolekylviktsplaster
FI914695A7 (fi) Niittain
FI925531L (fi) Process foer framstaellning av poroesa cellulosamatriser
FI931667A7 (fi) Indolderivat
BR9100241A (pt) Composicao detergente
BR9104059A (pt) Composicao detergente
FI921491L (fi) Antimalariakompositioner.
FI915315A7 (fi) Silikaattikoostumus
MX9100018A (es) Histidinas sustituidas
DE69128614D1 (de) Reinigungsmittelzusammensetzung
BR9104316A (pt) Composicoes de organossilicio
DE69133154D1 (de) Detergentzusammensetzung
FI923865L (fi) Monoatsopigmentkompositioner
FI930894A0 (fi) Form foer flotationsprodukter
NO912598D0 (no) Hypokalori-matsammensetning.
FI924674L (fi) En foerbaettrad process foer framstaellning av substituerade indolanderivat
FI912684A7 (fi) Muotinirrotusainekoostumuksia
DE69027139D1 (de) Zusammensetzungen
ID981B (id) Komposisi-komposisi sabun
FI88609B (fi) Kompostor
BR9100459A (pt) Composicao
FI913464A7 (fi) Menetelmä 1-hydroksimetyylipyratsolien valmistamiseksi